Skip to main content

Home
About the Journal
Policies
For Authors
Contacts

Pharmacognosy Research

An Open Access Journal in Pharmacognosy and Natural Products

Pharmacognosy Research

Articles in Press
Current Issue
Past Issues
Search Articles
Submit Article

Home / Pharmacognosy Research, Vol 13, Issue 2, Apr-Jun, 2021

Pharmacognosy Research, Vol 13, Issue 2, Apr-Jun, 2021

Submitted by webadmin on Sat, 06/19/2021 - 10:13

RETRACTED: The Role of Physalis angulata as Potential Anti-Type 2 Diabetic Agent
Foliar Epidermal Study on Selected Medicinal Plants Used in Homeopathy
Leaf Extracts of Glyphaea brevis Attenuate High Blood Glucose and Lipids in Diabetic Rats Induced with Streptozotocin
Isolation, Characterization, and Optimization of Protease‑Producing Bacterium Bacillus thuringiensis from Paddy Field Soil
Herbs and Medications Used for Treatment and Prophylaxis of Influenza Infections Including H5N1, H1N1, SARS‑CoV, and SARS‑CoV‑2

RETRACTED: The Role of Physalis angulata as Potential Anti-Type 2 Diabetic Agent ›

About

Pharmacognosy Research (Pharmacogn Res.)

[ISSN: Print -0976-4836, Online - 0974-8490] [http://www.phcogres.com], It provides peer-reviewed original research articles from the field of Natural Products. The journal serves an international audience of scientists and researchers in a variety of research and academia by quickly disseminating research findings related to Medicinal Plants and Natural Products.

It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submissions of original contributions in all areas of pharmacognosy are welcome.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
EMBASE/ Excerpta Medica, Emerging Sources Citation Index, Index Copernicus, Web of Science

For any other information, write to editor.phcogres@phcog.net

Search form

Announcement

ESCI

We are pleased to inform you that the Pharmacognosy Research is now covered by Clarivate Analytics (formerly Thomson Reuters) products and services. The journal is indexed and abstracted in Emerging Sources Citation Index (ESCI) since 2017. The ESCI is a new index in the Web of Science Core Collection.

Tags

(-)-Epicatechin

1

1- diphenyl-2-picrylhydrazyl

1-diphenyl-2-picryl-hydrazil); Ferric Reducing Antioxidant Power

1-diphenyl-2-picrylhydrazyl-radical scavenging assay

10‑di‑epi‑Cubenol

12-didehydroandrographolide

12‑epilycodoline N‑oxide

14-deoxyandrographolide

15-lipoxygenase inhibitory activity

16S ribosomal RNA

16S rRNA

18S Ribosomal ribonucleic acid

1H‑NMR

1‑Diphenyl‑1‑picrylhydrazyl

1‑diphenyl‑2‑picrylhydrazyl

1‑Diphenyl‑2‑picrylhydrazyl

1‑diphenyl‑2‑trinitrophenylhydrazine scavenger

2

2-Benzenedicarboxylic acid diisooctyl ester

2-diphenyl-1-picrylhydrazyl

2-diphenyl-1-picrylhydrazylDPPH

25‑dien‑3‑ol.

2‑diphenyl‑1‑picrylhydrazyl

2‑diphenyl‑1‑picrylhydrazyl radical

2’ azino bis (ethylbenzthiazolene‑6‑sulfonic acid) radical cation assay

2’‑azino‑bis (3‑ethylbenzothiazoline‑6‑sulfonic acid)

2’‑Diphenyl‑1‑picrylhydrazyl

3

3 (4

3 β-taraxerol.

3(4

3-(4

3-dimethyl

3CLPRO

3T3-L1

3T3‑L1

3T3‑L1 cell lines

3‑(4

3‑(S)‑hexahydroxydiphenoyl‑D‑glucose

3’

3’‑hydroxy‑5

4

4-caffeoylquinic acid

4NQO

4‑dinitrobenzene

4‑hydroxyacetophenone

Copyright © 2024 Phcog.Net. All rights reserved. | Powered by Manuscript TechnoMedia LLP.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Last updated: 01/06/2021